{"nctId":"NCT01422915","briefTitle":"Sorbent Therapy of the Cutaneous Porphyrias","startDateStruct":{"date":"2011-05"},"conditions":["Erythropoietic Protoporphyria"],"count":4,"armGroups":[{"label":"colestipol treatment","type":"EXPERIMENTAL","interventionNames":["Drug: Colestipol"]}],"interventions":[{"name":"Colestipol","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Adult over age 21\n* healthy\n\nExclusion Criteria:\n\n* Intercurrent illness\n* pregnancy","healthyVolunteers":true,"sex":"ALL","minimumAge":"22 Years","maximumAge":"60 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Photosensitivity, Assessed by Measuring the Number of Minutes of Sun Tolerance","description":"Minutes of sun tolerance","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"65.8","spread":"58.8"}]}]}]},{"type":"PRIMARY","title":"Protoporphyrin Concentration in Blood","description":"1. erythrocyte protoporphyrin concentration, ug/dl\n2. plasma protoporphyrin concentration, ug/dl","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1712","spread":"455"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.8","spread":"8.3"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":4},"commonTop":[]}}}